TGA · AHPRA · FSANZ · ACCC

    What are the advertising rules for Traditional Chinese Medicine practitioners in Australia?

    CompliGUARD reviews this compliance area against TGA · AHPRA · FSANZ · ACCC frameworks for Australian health brands — here's what the regulations say.

    CompliGUARD reviews TCM practitioner advertising against AHPRA's advertising rules under the National Law. Traditional Chinese Medicine practitioners — including acupuncturists, Chinese herbal medicine practitioners, and Chinese medicine practitioners — are registered with AHPRA under the Chinese Medicine Board of Australia and must comply with s.133 of the Health Practitioner Regulation National Law across all advertising.

    The rule: Health Practitioner Regulation National Law, s.133; AHPRA Guidelines for Advertising a Regulated Health Service, December 2020; Chinese Medicine Board of Australia Advertising Guidance

    Traditional Chinese Medicine (TCM) is one of the regulated health professions under AHPRA. The Chinese Medicine Board of Australia regulates practitioners across four divisions: Chinese herbal medicine, acupuncture, Chinese medicine (combining both), and Chinese herbal dispensing. All four divisions are subject to s.133 and the AHPRA Guidelines for Advertising a Regulated Health Service. The Chinese Medicine Board has published advertising guidance that supplements the AHPRA Guidelines, with specific attention to TCM-specific claim areas including meridian theory, qi and energy-based claims, and the use of traditional Chinese medicine frameworks in advertising directed at a contemporary health consumer audience. TCM practitioners who also sell or recommend Chinese herbal medicine products face dual obligations under s.133 for service advertising and the TGA Advertising Code for Listed Medicine product promotion.

    What this means in practice

    • Do not publish patient testimonials in any form — the s.133(1)(c) prohibition applies to all four registration divisions under the Chinese Medicine Board.
    • Apply particular care to TCM-specific claim language — claims about qi, meridians, energy balance, and constitutional health may be consistent with traditional TCM frameworks but can create unrealistic expectations of benefit under s.133(1)(c) when directed at a general consumer audience.
    • For Chinese herbal medicine products with AUST L listings: apply TGA Advertising Code requirements including mandatory statements to all product advertising — separate from s.133 service advertising obligations.
    • Do not claim superiority of TCM over conventional medicine or other health modalities without substantiated evidence — such claims engage s.133(1)(d).
    • Retain pre-publication compliance records for all advertising — AHPRA's monitoring tools scan TCM practitioner digital content.

    Common mistakes

    Mistake

    Using TCM theoretical framework language as outcome claims in consumer advertising

    Problem

    Statements rooted in TCM theory — 'restores the flow of qi', 'clears heat and resolves dampness', 'tonifies kidney yang' — may be accurate within the TCM clinical framework but can be misleading or create unrealistic expectations when used in consumer advertising directed at a general audience unfamiliar with TCM concepts. AHPRA assesses advertising from the perspective of a reasonable consumer, not a TCM-literate audience.

    Fix

    Where using TCM theoretical concepts in advertising, provide plain-language context that accurately describes what the consumer can reasonably expect from treatment — without implying specific physiological outcomes that the evidence does not support.

    Mistake

    Publishing patient outcome accounts for acupuncture or herbal treatment

    Problem

    Patient accounts of their experience with TCM treatment — whether for acupuncture, herbal medicine, or Chinese medicine generally — constitute testimonials under s.133(1)(c) regardless of how they are framed. This includes stories shared by practitioners with patient consent.

    Fix

    Replace patient outcome accounts with educational content about the TCM assessment process, what conditions TCM is used for, and the current evidence base for acupuncture and Chinese herbal medicine.

    Mistake

    Failing to apply TGA mandatory statements to Chinese herbal medicine product advertising

    Problem

    Many Chinese herbal medicine products are Listed Medicines on the ARTG. Advertising these products — including in clinic social media posts or clinic product pages — without AUST numbers and mandatory statements is a TGA Advertising Code breach, separate from and in addition to any s.133 issues.

    Fix

    Identify all Chinese herbal medicine products you stock or recommend that hold AUST L numbers and apply TGA mandatory statement requirements to all advertising of those products.

    Compliant vs non-compliant example

    ❌ NON-COMPLIANT

    Using TCM theoretical framework language as outcome claims in consumer advertising

    ✅ COMPLIANT

    Where using TCM theoretical concepts in advertising, provide plain-language context that accurately describes what the consumer can reasonably expect from treatment — without implying specific physiological outcomes that the evidence does not support.

    The enforcement context

    The Chinese Medicine Board of Australia monitors advertising compliance for TCM practitioners. AHPRA's automated monitoring tools scan TCM practitioner websites and social media. In 2024–25, AHPRA assessed 775 advertising complaints across all registered professions — TCM practitioners are represented in this data. Penalties for s.133 breaches reach $60,000 per offence for individuals. TGA enforcement applies separately to Chinese herbal medicine product advertising.

    Before you publish, check it.

    CompliGUARD reviews TCM practitioner advertising against AHPRA Guidelines s.133 and TGA Advertising Code requirements for Chinese herbal medicine products — covering service and product advertising simultaneously.

    Start free review

    Related questions

    Regulatory references

    • Health Practitioner Regulation National Law, s.133
    • AHPRA Guidelines for Advertising a Regulated Health Service, December 2020
    • Chinese Medicine Board of Australia — Advertising Guidance
    • Therapeutic Goods Advertising Code 2021 (Cth), s.14–16 (for AUST L Chinese herbal medicine products)